UNITED STATES PA TENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Addrnssc COMMISSIONER FOR PA TENTS
`P.O. Box 1450
`Alexamlria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`17/498,642
`
`10/11/2021
`
`Richard Quick
`
`l l 1552.8023.US02
`
`1040
`
`25096
`7590
`06/25/2024
`PERKINS COTE LLP - SEA General
`PATENT-SEA
`P.O. BOX 1247
`SEATTLE, WA 98111-1247
`
`EXAMINER
`
`NGUYEN, TCAN VAN
`
`ART UNIT
`
`PAPER NUMBER
`
`3771
`
`NOTIFICATION DATE
`
`DELIVERY MODE
`
`06/25/2024
`
`ELECTRONIC
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time period for reply, if any, is set in the attached communication.
`
`Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the
`following e-mail address(es):
`patentprocurement@perkinscoie.com
`
`PTOL-90A (Rev. 04/07)
`
`Imperative Care v. Inari Medical
`US Patent 12,016,580
`Imperative Care Ex. 1002
`INARI_017207
`
`-1-
`
`

`

`APPLICATION NO.
`
`17/498,642
`
`ISSUE DATE
`
`25-Jun-2024
`
`PATENT NO.
`
`12016580
`
`PERKINS COIE LLP - SEA General
`PATENT-SEA
`P.O. BOX 1247
`SEATTLE, WA 98111-1247
`
`EGRANT NOTIFICATION
`
`Your electronic patent grant (eGrant) is now available, which can be accessed via Patent Center at https://
`patentcenter .uspto.gov
`
`The electronic patent grant is the official patent grant under 35 U.S.C. 153. For more information, please visit
`https://www.uspto.gov/electronicgrants
`
`page 1 of 1
`
`INARI_017208
`
`-2-
`
`

`

`UNITED STATES PA TENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Addrnss, COMMISSIONER FOR PA TENTS
`P.O. Box 1450
`Alexamlria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`17/498,642
`
`ISSUE DATE
`
`06/25/2024
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`12016580
`
`111552.8023.US02
`
`1040
`
`06/05/2024
`7590
`25096
`PERKINS COIE LLP - SEA General
`PATENT-SEA
`P.O. BOX 1247
`SEATTLE, WA 98111-1247
`
`ISSUE NOTIFICATION
`The projected patent number and issue date arc specified above. The patent will issue electronically. The
`electronically issued patent is the official patent grant pursuant to 35 U.S.C. § 153. The patent may be accessed
`on or after the issue date through Patent Center at https://patentcenter.uspto.gov/. The patent will be available in
`both the public and the private sides of Patent Center. Further assistance in electronically accessing the patent,
`or about Patent Center, is available by calling the Patent Electronic Business Center at 1-888-217-9197.
`
`The USPTO is implementing electronic patent issuance with a transition period, during which period the
`USPTO will mail a ceremonial paper copy of the electronic patent grant to the correspondence address of
`record. Additional copies of the patent (i.e., certified and presentation copies) may be ordered for a fee from the
`USPTO's Certified Copy Center at https://certifiedcopycenter.uspto.gov/index.html. The Certified Copy Center
`may be reached at (800)972-6382.
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is O day(s). Any patent to issue from the above-identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Center (https://
`patentcenter.uspto.gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office
`of Patent Legal Administration at ( 571 )-272-7702. Questions relating to issue and publication fee payments should
`be directed to the Application Assistance Unit (AAU) of the Office of Patents Stakeholder Experience (OPSE),
`Stakeholder Support Division (SSD) at (571)-272-4200.
`
`IR103 (Rev. 10/09)
`
`INARI_017209
`
`-3-
`
`

`

`INVENTOR(s) (Please see PATENT CENTER site https://patentcenter.uspto.gov for additional inventors):
`
`Richard Quick, Mission Viejo, CA;
`Benjamin Edward Merritt, San Clemente, CA;
`John Coleman Thress, Capistrano Beach, CA;
`Paul Lubock, Monarch Beach, CA;
`Thomas M. Tu, Louisville, KY;
`
`APPLICANT( s) (Please see PA TENT CENTER site https://patentcenter.uspto.gov for additional applicants):
`
`Inari Medical, Inc., Irvine, CA;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SclectUSA.gov.
`
`IR103 (Rev. 10/09)
`
`INARI_017210
`
`-4-
`
`

`

`Receipt date: 09/06/2022
`
`17/498 , 6 4 2 -· GAU : 3 7 71
`
`Doc code: IDS
`Doc description: Information Disclosure Statement (IDS) Filed
`
`PTO/SB/08a (OHO)
`Approved for use through 07/31/2012. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Not for submission under 37 CFR 1.99)
`
`Application Number
`17/498,642- Conf# 1040
`Filing Date
`October 11, 2021
`First Named Inventor
`Richard Quick
`Art Unit
`Not Yet Assigned
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number 111552-8023. US02
`
`194.
`
`195.
`
`196.
`
`197.
`
`198.
`
`Change(s
`
`to docum,
`
`I· 1~9.
`all 200.
`nt,
`201.
`
`/o.F✓
`11/20/2(
`27
`
`202.
`
`203.
`
`204.
`
`205.
`
`206.
`
`207.
`
`208.
`
`209.
`
`210.
`
`20150032144
`
`01-29-2015
`
`Holloway
`
`20150059908
`
`03-05-2015
`
`Mallen
`
`20150088190
`
`03-26-2015
`
`Jensen
`
`20150127035
`
`05-07-2015
`
`Trapp et al.
`
`20150133990
`
`20150150672
`
`20150164523
`
`05-14-2015
`OS 8~ ii!Q~;i:
`06-18-2015
`
`Davidson
`
`Ma
`
`Brady et al.
`
`06/2015
`
`20150164666
`
`06-18-2015
`
`Johnson et al.
`
`20150190155
`
`20150190156
`
`07-09-2015
`
`07-09-2015
`
`Ulm Ill
`
`Ulm Ill
`
`20150196380
`
`07-16-2015
`
`Berrada et al.
`
`20150196744
`
`04-03-2018
`
`Aboytes
`
`20150209058
`
`07-30-2015
`
`Ferrera et al.
`
`20150209165
`
`07-30-2015
`
`Grandfield et al.
`
`20150238207
`
`08-27-2015
`
`Cox et al.
`
`20150250578
`
`09-10-2015
`
`Cook et al.
`
`Cooper et al.
`
`20150265299
`
`09-24-2015
`
`20150305756
`
`10-29-2015
`
`Rosenbluth
`
`20150305859
`
`10-29-2015
`
`Eller
`
`20150352325
`
`20150360001
`
`20150374391
`
`12-10-2015
`
`12-17-2015
`
`12-31-2015
`
`Quick
`
`Quick
`
`Quick
`
`20160008014
`
`08-09-2016
`
`Rosenbluth
`
`20160022293
`
`01-28-2016
`
`Dubrul et al.
`
`20160058540
`
`03-03-2016
`
`Don Michael
`
`20160074627
`
`03-17-2016
`
`Cottone
`
`20160106448
`
`04-21-2016
`
`Brady et al.
`
`20160106449
`
`04-21-2016
`
`Brady et al.
`
`20160113663
`
`04-28-2016
`
`Brady et al.
`
`20160113664
`
`04-28-2016
`
`Brady et al.
`
`20160113665
`
`04-28-2016
`
`Brady et al.
`
`20160113666
`
`04-28-2016
`
`Quick
`
`20160143721
`
`05-26-2016
`
`Rosenbluth
`
`211.
`
`212.
`
`213.
`
`214.
`
`215.
`
`216.
`
`217.
`
`218.
`
`219.
`
`220.
`
`221.
`
`222.
`
`223.
`
`224.
`
`225.
`
`226.
`
`158124198.1
`
`18
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/T.V.N/
`
`INARI_017211
`
`-5-
`
`

`

`UNITED STATES PA TENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Addrnssc COMMISSIONER FOR PA TENTS
`P.O. Box 1450
`Alexamlria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`17/498,642
`
`10/11/2021
`
`Richard Quick
`
`l l 1552.8023.US02
`
`1040
`
`25096
`7590
`05/01/2024
`PERKINS COTE LLP - SEA General
`PATENT-SEA
`P.O. BOX 1247
`SEATTLE, WA 98111-1247
`
`EXAMINER
`
`NGUYEN, TCAN VAN
`
`ART UNIT
`
`PAPER NUMBER
`
`3771
`
`NOTIFICATION DATE
`
`DELIVERY MODE
`
`05/01/2024
`
`ELECTRONIC
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time period for reply, if any, is set in the attached communication.
`
`Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the
`following e-mail address(es):
`patentprocurement@perkinscoie.com
`
`PTOL-90A (Rev. 04/07)
`
`INARI_017212
`
`-6-
`
`

`

`Supplemental
`Notice of Allowability
`
`Application No.
`17/498,642
`Examiner
`TUAN V NGUYEN
`
`Applicant(s)
`Quick et al.
`Art Unit
`3771
`
`I AIA (FITF) Status
`
`Yes
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address-(cid:173)
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application. If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1.~ This communication is responsive to the Information Disclosure Statement filed February 14, 2024.
`DA declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on __ .
`
`2.0 An election was made by the applicant in response to a restriction requirement set forth during the interview on __ ; the
`restriction requirement and election have been incorporated into this action.
`
`3.~ The allowed claim(s) is/are 21-31 and 41-63. As a result of the allowed claim(s), you may be eligible to benefit from the Patent
`Prosecution Highway program at a participating intellectual property office for the corresponding application. For more information
`, please see http://www.uspto.gov/patents/init_events/pph/index.jsp or send an inquiry to PPHfeedback@uspto.gov.
`
`4.0 Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119(a)-(d) or (f).
`Certified copies:
`b) 0 Some*
`c) 0 None of the:
`a) □All
`1. 0 Certified copies of the priority documents have been received.
`2. 0 Certified copies of the priority documents have been received in Application No. __ .
`3. 0 Copies of the certified copies of the priority documents have been received in this national stage application from the
`International Bureau (PCT Rule 17.2(a)).
`
`* Certified copies not received: __ .
`
`Applicant has THREE MONTHS FROM THE "MAILING DATE" of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABANDONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`
`5.0 CORRECTED DRAWINGS (as "replacement sheets") must be submitted.
`0
`including changes required by the attached Examiner's Amendment/ Comment or in the Office action of
`PaperNoJM~ID~e __ .
`Identifying indicia such as the application number {see 37 CFR 1.84{c)) should be written on the drawings in the front {not the back) of each
`sheet. Replacement sheet{s) should be labeled as such in the header according to 37 CFR 1.121{d).
`
`6.0 DEPOSIT OF and/or INFORMATION about the deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner's comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Attachment(s)
`1. 0 Notice of References Cited (PTO-892)
`2.~ Information Disclosure Statements (PTO/SB/08),
`Paper No./Mail Date
`.
`3. 0 Examiner's Comment Regarding Requirement for Deposit
`of Biological Material
`.
`4.0 Interview Summary (PTO-413),
`Paper No./Mail Date. __ .
`/TUAN V NGUYEN/
`Primary Examiner, Art Unit 3771
`
`5. 0 Examiner's AmendmenVComment
`6. 0 Examiner's Statement of Reasons for Allowance
`
`7. 0 Other __
`
`U.S. Patent and Trademark Office
`PTOL-37 (Rev. 08-13)
`
`Notice of Allowability
`
`Part of Paper No./Mail Date 20240428
`
`INARI_017213
`
`-7-
`
`

`

`Receipt date: 02/14/2024
`
`17/498 , 6 4 2
`
`-· GAU : 3 7 71
`
`Doc code: IDS
`Doc description: Information Disclosure Statement (IDS) Filed
`
`PTO/SB/08a (01-10)
`Approved for use through 07/31/2012. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Not for submission under 37 CFR 1.99)
`
`Application Number
`17 /498,642- Conf# 1040
`Filing Date
`October 11, 2021
`First Named Inventor
`Richard Quick
`Art Unit
`3771
`Examiner Name
`Tuan Van Nguyen
`Attorney Docket Number 111552-8023.US02
`
`Examiner Cite
`Initial*
`No
`
`Patent Number
`
`Issue Date
`
`Name of Patentee or Applicant of cited
`Document
`
`Pages, Columns, Lines, Where
`Relevant Passages or Relevant
`Figures Appear
`
`U.S. PATENTS AND PUBLICATIONS
`
`11890180
`
`20140163615
`5323514
`
`5911728
`
`02-06-2024
`
`Merritt et al.
`
`06-12-2014
`06-28-1994
`
`Gadlage et al.
`
`Masuda et al.
`
`06-15-1999
`
`Sepetka et al.
`
`20200129741
`
`04-30-2020
`
`Ka\/\/Was et al.
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`FOREIGN PATENT DOCUMENTS
`
`Examiner Cite Foreign Document
`Number3
`Initial*
`No
`
`Publication Date
`
`Pages, Columns,
`Name of Patentee or Applicant of cited Document Lines, Where
`Relevant Passages
`or Relevant Figures
`Appear
`
`T5
`
`WO2012114633
`
`08-30-2012
`
`TERUMO KABUSHIKI KAISHA
`
`NON-PATENT LITERATURE DOCUMENTS
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item (book, T'
`Examiner Cite
`No magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume-issue number(s), publisher, city and/or country
`Initials*
`where published.
`
`English translation of Japanese Office Action received for JP Application No. 2022-574456, Applicant: lnari
`Medical, Inc, Date of Mailing: January 23, 2024, 12 pages.
`
`EXAMINER SIGNATURE
`I Date Considered
`Examiner Signature
`/TUAN V NGUYEN/
`I 04/28/2024
`I
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line
`through a citation if not in conformance and not considered. Include copy of this form with next communication
`to applicant.
`1 See Kind Codes of US PTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-
`letter code (WIPO Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the
`serial number of the patent document. 4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard
`ST.16 if possible. 5 Applicant is to place a check mark here if English language translation is attached.
`
`165557650.1
`
`1
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/T.V.N/
`
`INARI_017214
`
`-8-
`
`

`

`Receipt date: 02/14/2024
`
`17/498 , 6 4 2 -· GAU : 3 7 71
`
`Doc code: IDS
`Doc description: Information Disclosure Statement (IDS) Filed
`
`PTO/SB/08a (01-10)
`Approved for use through 07/31/2012. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Not for submission under 37 CFR 1.99)
`
`Application Number
`17 /498,642- Conf# 1040
`Filing Date
`October 11, 2021
`First Named Inventor
`Richard Quick
`Art Unit
`3771
`Examiner Name
`Tuan Van Nguyen
`Attorney Docket Number 111552-8023.US02
`
`CERTIFICATION STATEMENT
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`D That each item of information contained in the information disclosure statement was first cited in any communication from
`a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the information
`disclosure statement. See 37 CFR 1.97(e) (1).
`
`OR
`
`D That no item of information contained in the information disclosure statement was cited in a communication from a foreign
`patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification after making
`reasonable inquiry, no item of information contained in the information disclosure statement was known to any individual
`designated in 37 CFR 1.56( c) more than three months prior to the filing of the information disclosure statement. See 37
`CFR 1.97(e) (2).
`D See attached certification statement.
`D Fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`[gl None
`
`It is submitted that the Information Disclosure Statement is in compliance with 37 C.F.R. § 1.98 and the Examiner is
`respectfully requested to consider the listed references. This Information Disclosure Statement is not to be construed as a
`representation that: (i) a search has been made; (ii) additional information that may be material to the examination of this
`application does not exist; (iii) the information, protocols, results and the like reported by third parties are accurate or enabling;
`or (iv) the cited information is, or is considered to be, material to patentability. In addition, Applicant does not admit that any
`enclosed item of information constitutes prior art to the subject invention and specifically reserves the right to demonstrate
`that any such reference is not prior art.
`
`COPIES OF REFERENCES
`
`In accordance with 37 C.F.R. § 1.98(a)(2)(ii), Applicant has not submitted copies of U.S. patents and U.S. patent applications.
`Applicant submits herewith copies of foreign patents and non-patent literature in accordance with 37 C. F.R. § 1.98(a)(2).
`
`SIGNATURE
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`I /Matthew S. Williams/
`I Matthew S. Williams
`
`I Date (YYYY-MM-DD)
`Signature
`I Registration Number
`Name/Print
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by
`the US PTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 1 hour to complete,
`including gathering, preparing and submitting the completed application form to the US PTO. Time will vary depending upon the individual case. Any comments
`on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent
`and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
`ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`I 2024-02-14
`I n,s16
`
`165557650.1
`
`2
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/T.V.N/
`
`INARI_017215
`
`-9-
`
`

`

`UNITED STATES PA TENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Addrnssc COMMISSIONER FOR PA TENTS
`P.O. Box 1450
`Alexamlria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`17/498,642
`
`10/11/2021
`
`Richard Quick
`
`l l 1552.8023.US02
`
`1040
`
`25096
`7590
`03/2712024
`PERKINS COTE LLP - SEA General
`PATENT-SEA
`P.O. BOX 1247
`SEATTLE, WA 98111-1247
`
`EXAMINER
`
`NGUYEN, TCAN VAN
`
`ART UNIT
`
`PAPER NUMBER
`
`3771
`
`NOTIFICATION DATE
`
`DELIVERY MODE
`
`03/27/2024
`
`ELECTRONIC
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time period for reply, if any, is set in the attached communication.
`
`Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the
`following e-mail address(es):
`patentprocurement@perkinscoie.com
`
`PTOL-90A (Rev. 04/07)
`
`INARI_017216
`
`-10-
`
`

`

`Supplemental
`Notice of Allowability
`
`Application No.
`17/498,642
`Examiner
`TUAN V NGUYEN
`
`Applicant(s)
`Quick et al.
`Art Unit
`3771
`
`I AIA (FITF) Status
`
`Yes
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address-(cid:173)
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application. If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1.~ This communication is responsive to the filling of Information Disclosure Statement on February 26, 2024.
`DA declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on __ .
`
`2.0 An election was made by the applicant in response to a restriction requirement set forth during the interview on __ ; the
`restriction requirement and election have been incorporated into this action.
`
`3.~ The allowed claim(s) is/are 21-31 and 41-63. As a result of the allowed claim(s), you may be eligible to benefit from the Patent
`Prosecution Highway program at a participating intellectual property office for the corresponding application. For more information
`, please see http://www.uspto.gov/patents/init_events/pph/index.jsp or send an inquiry to PPHfeedback@uspto.gov.
`
`4.0 Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119(a)-(d) or (f).
`Certified copies:
`b) 0 Some*
`c) 0 None of the:
`a) □All
`1. 0 Certified copies of the priority documents have been received.
`2. 0 Certified copies of the priority documents have been received in Application No. __ .
`3. 0 Copies of the certified copies of the priority documents have been received in this national stage application from the
`International Bureau (PCT Rule 17.2(a)).
`
`* Certified copies not received: __ .
`
`Applicant has THREE MONTHS FROM THE "MAILING DATE" of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABANDONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`
`5.0 CORRECTED DRAWINGS (as "replacement sheets") must be submitted.
`0
`including changes required by the attached Examiner's Amendment/ Comment or in the Office action of
`PaperNoJM~ID~e __ .
`Identifying indicia such as the application number {see 37 CFR 1.84{c)) should be written on the drawings in the front {not the back) of each
`sheet. Replacement sheet{s) should be labeled as such in the header according to 37 CFR 1.121{d).
`
`6.0 DEPOSIT OF and/or INFORMATION about the deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner's comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Attachment(s)
`1. 0 Notice of References Cited (PTO-892)
`2.~ Information Disclosure Statements (PTO/SB/08),
`Paper No./Mail Date
`.
`3. 0 Examiner's Comment Regarding Requirement for Deposit
`of Biological Material
`.
`4.0 Interview Summary (PTO-413),
`Paper No./Mail Date. __ .
`/TUAN V NGUYEN/
`Primary Examiner, Art Unit 3771
`
`5. 0 Examiner's AmendmenVComment
`6. 0 Examiner's Statement of Reasons for Allowance
`
`7. 0 Other __
`
`U.S. Patent and Trademark Office
`PTOL-37 (Rev. 08-13)
`
`Notice of Allowability
`
`Part of Paper No./Mail Date 20240322
`
`INARI_017217
`
`-11-
`
`

`

`Receipt date: 02/26/2024
`
`17/498 , 6 4 2
`
`-· GAU : 3 7 71
`
`Doc code: IDS
`Doc description: Information Disclosure Statement (IDS) Filed
`
`PTO/SB/08a (01-10)
`Approved for use through 07/31/2012. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Not for submission under 37 CFR 1.99)
`
`17 /498,642- Conf# 1040
`October 11, 2021
`
`Application Number
`Filing Date
`First Named Inventor
`Art Unit
`Examiner Name
`Tuan Van Nguyen
`Attorney Docket Number 111552-8023.US02
`
`Richard Quick
`3771
`
`Examiner Cite
`Initial*
`No
`
`Patent Number
`
`Issue Date
`
`Name of Patentee or Applicant of cited
`Document
`
`Pages, Columns, Lines, Where
`Relevant Passages or Relevant
`Figures Appear
`
`U.S. PATENTS AND PUBLICATIONS
`
`20200129741
`
`2018014840
`20240058113
`
`04-30-2020
`
`Ka\/\/Was et al.
`
`01-18-2018
`02-22-2024
`
`Panian
`
`Strauss et al.
`
`1.
`
`2.
`
`3.
`
`4.
`5.
`
`FOREIGN PATENT DOCUMENTS
`
`Examiner Cite Foreign Document
`Initial*
`No
`Number3
`
`Publication Date
`
`Pages, Columns,
`Name of Patentee or Applicant of cited Document Lines, Where
`Relevant Passages
`or Relevant Figures
`Appear
`
`T5
`
`NON-PATENT LITERATURE DOCUMENTS
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item (book, T'
`Examiner Cite
`No magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume-issue number(s), publisher, city and/or country
`Initials*
`where published.
`
`Chinese First Office Action received for CN Application No. 201980067623.1, Applicant: lnari Medical, Inc.,
`Date of Mailing: January 31, 2024, 10 pages.
`
`EXAMINER SIGNATURE
`I Date Considered
`03/22/2024
`/TUAN V NGUYEN/
`Examiner Signature
`I
`I
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line
`through a citation if not in conformance and not considered. Include copy of this form with next communication
`to applicant.
`
`1 See Kind Codes of US PTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-
`letter code (WIPO Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the
`serial number of the patent document. 4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard
`ST.16 if possible. 5 Applicant is to place a check mark here if English language translation is attached.
`
`165736324.1
`
`1
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/T.V.N/
`
`INARI_017218
`
`-12-
`
`

`

`Receipt date: 02/26/2024
`
`17/498 , 6 4 2 -· GAU : 3 7 71
`
`Doc code: IDS
`Doc description: Information Disclosure Statement (IDS) Filed
`
`PTO/SB/08a (01-10)
`Approved for use through 07/31/2012. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Not for submission under 37 CFR 1.99)
`
`Application Number
`17 /498,642- Conf# 1040
`Filing Date
`October 11, 2021
`First Named Inventor
`Richard Quick
`Art Unit
`3771
`Examiner Name
`Tuan Van Nguyen
`Attorney Docket Number 111552-8023.US02
`
`CERTIFICATION STATEMENT
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`D That each item of information contained in the information disclosure statement was first cited in any communication from
`a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the information
`disclosure statement. See 37 CFR 1.97(e) (1).
`
`OR
`
`D That no item of information contained in the information disclosure statement was cited in a communication from a foreign
`patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification after making
`reasonable inquiry, no item of information contained in the information disclosure statement was known to any individual
`designated in 37 CFR 1.56( c) more than three months prior to the filing of the information disclosure statement. See 37
`CFR 1.97(e) (2).
`D See attached certification statement.
`D Fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`[gl None
`
`It is submitted that the Information Disclosure Statement is in compliance with 37 C.F.R. § 1.98 and the Examiner is
`respectfully requested to consider the listed references. This Information Disclosure Statement is not to be construed as a
`representation that: (i) a search has been made; (ii) additional information that may be material to the examination of this
`application does not exist; (iii) the information, protocols, results and the like reported by third parties are accurate or enabling;
`or (iv) the cited information is, or is considered to be, material to patentability. In addition, Applicant does not admit that any
`enclosed item of information constitutes prior art to the subject invention and specifically reserves the right to demonstrate
`that any such reference is not prior art.
`
`COPIES OF REFERENCES
`
`In accordance with 37 C.F.R. § 1.98(a)(2)(ii), Applicant has not submitted copies of U.S. patents and U.S. patent applications.
`Applicant submits herewith copies of foreign patents and non-patent literature in accordance with 37 C. F.R. § 1.98(a)(2).
`
`SIGNATURE
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`I /Matthew S. Williams/
`I Matthew S. Williams
`
`I Date (YYYY-MM-DD)
`Signature
`I Registration Number
`Name/Print
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by
`the US PTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 1 hour to complete,
`including gathering, preparing and submitting the completed application form to the US PTO. Time will vary depending upon the individual case. Any comments
`on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent
`and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
`ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`I 2024-02-26
`I n,s16
`
`165736324.1
`
`2
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/T.V.N/
`
`INARI_017219
`
`-13-
`
`

`

`By fax. send to:
`
`(571) 273-2885
`
`PART B -- FEE(S) TRANS MITT AL
`Complete and send this form, togetherv,ith the applicable fcc(s), by mail or fax, or via EFS-W cb.
`By rnaiL send to:
`Mail S'top ISSUE FEE
`Commissioner for Pa1 ents
`PO Box 1450
`Alexandria. VA 22313-l 450
`lN SlRUC't10NS: Ihis:fC>rm should beusedfor transnittingtheJSSUE FEE andPUl-JLICA'llON FEE (jfrequJred). Blocks l through5 should becornplekd where approprJate.
`All farther correspondence w:dl be m1,iled to the current correspondence ,1dd.ress as ind.1c.Jted unless corre.;:ted belo\v or directed othe_rv,rjse jn Bloc.k], by (a} specit~,,ring a n~v
`cmTespondence address; and/or (b) indicating a separate·' FEE ADDRESS" for 1n:1intenance fee notifications. Bera use eh~ctronic patent issuance may on:ur shorti} afta(cid:173)
`issue fee payment, any desired nrntinuing applicatirrn should preferably be filed l-"·in,· to payment of this issue fee in order ,wt to jeopardi,.e mpendency.
`Note. A ceni1i:cate of .rnail~ng cari only be used for dom:;stic rmjlirigs of· the
`ClJRRE::JT CORRESPONDENCE ADDRESS (Note: lJse Block J for any change of.address)
`25096
`F~t:(s) Tnm~milli1L This .__:t:rf~f.ca!t: '-~i1IlJHJf bt: m~~<lfor any ofh~rc.c.;umpanying
`paper-.. -Each .additinn;:i! paper, r-:uch ?.t,; an assignn1ent or fnnnal dravvlng, must
`Perkins Coie LLP
`have its o,vn certificate ofnmi1ing or trnnsnlissicm.
`P.O. Box 1247
`Certifirate of l\.!ailing or Trnnsmission
`PATENT - SEA
`1 hereby ce:rtify that this Fee{s) Tran•anittal is being deposited vvith the United
`States Postal ServJce w1th sufficient post,1ge fur first cl,1ss nuil in an envelo!_Y(cid:173)
`Seattle, WA, 981 "11-1247
`addrnssed to the IvfaiJ Stop ISSUE FEE addn;ss obove, or lxlng tronsmiHtXl to the
`us
`.. _,
`,., .... ,. '
`_,,.,.
`TTSPTO ··ia EF" W,·b o·· bv fucs'miic. to 15, l) n1 2885 r··· th" dai•• lie-I ·1w
`' '
`) -"'
`~i-
`-"'
`JiYoung Anderson
`(lyped or pnnted nanie)
`/JiYoung Anderson/
`2024.02.28
`
`~, I -
`
`-
`
`-
`
`(Signature)
`
`(Date)
`
`APPLICATION NO
`17/498,642
`
`FILJ}J G JJ A TE
`Oct 11, 2021
`
`FIRST NA